Field JK - Search Results

1

Expression of the cell-cell adhesion molecule E-cadherin in squamous cell carcinoma of the head and neck.

Bowie GL, Caslin AW, Roland NJ, Field JK, Jones AS, Kinsella AR. Bowie GL, et al. Among authors: field jk. Clin Otolaryngol Allied Sci. 1993 Jun;18(3):196-201. doi: 10.1111/j.1365-2273.1993.tb00829.x. Clin Otolaryngol Allied Sci. 1993. PMID: 8365008

2

Oncogenes and tumour-suppressor genes in squamous cell carcinoma of the head and neck.

Field JK. Field JK. Eur J Cancer B Oral Oncol. 1992 Jul;28B(1):67-76. doi: 10.1016/0964-1955(92)90016-t. Eur J Cancer B Oral Oncol. 1992. PMID: 1330149 Review.

3

C-erbB-2 expression in squamous cell carcinoma of the head and neck.

Field JK, Spandidos DA, Yiagnisis M, Gosney JR, Papadimitriou K, Stell PM. Field JK, et al. Anticancer Res. 1992 May-Jun;12(3):613-9. Anticancer Res. 1992. PMID: 1377893

4

Multiple cytogenetic aberrations in squamous cell carcinomas of the head and neck.

Owens W, Field JK, Howard PJ, Stell PM. Owens W, et al. Among authors: field jk. Eur J Cancer B Oral Oncol. 1992 Jul;28B(1):17-21. doi: 10.1016/0964-1955(92)90006-m. Eur J Cancer B Oral Oncol. 1992. PMID: 1422465

5

A phase II study of cisplatinum versus cisplatinum + nifedipine in end-stage carcinoma of the head and neck.

Jones AS, Phillips DE, Field JK. Jones AS, et al. Among authors: field jk. Clin Otolaryngol Allied Sci. 1992 Dec;17(6):501-4. doi: 10.1111/j.1365-2273.1992.tb01705.x. Clin Otolaryngol Allied Sci. 1992. PMID: 1493624 Clinical Trial.

6

Low levels of ras p21 oncogene expression correlates with clinical outcome in head and neck squamous cell carcinoma.

Field JK, Yiagnisis M, Spandidos DA, Gosney JR, Papadimitriou K, Vaughan ED, Stell PM. Field JK, et al. Eur J Surg Oncol. 1992 Apr;18(2):168-76. Eur J Surg Oncol. 1992. PMID: 1582509

7

Elevated P53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neck.

Field JK, Spandidos DA, Malliri A, Gosney JR, Yiagnisis M, Stell PM. Field JK, et al. Br J Cancer. 1991 Sep;64(3):573-7. doi: 10.1038/bjc.1991.352. Br J Cancer. 1991. PMID: 1911200 Free PMC article.

8

c-myc oncoprotein in bronchial carcinoma: expression in all major morphological types.

Gosney JR, Field JK, Gosney MA, Lye MD, Spandidos DA, Butt SA. Gosney JR, et al. Among authors: field jk. Anticancer Res. 1990 May-Jun;10(3):623-8. Anticancer Res. 1990. PMID: 2164348

9

Elevated expression of the c-myc oncoprotein correlates with poor prognosis in head and neck squamous cell carcinoma.

Field JK, Spandidos DA, Stell PM, Vaughan ED, Evan GI, Moore JP. Field JK, et al. Oncogene. 1989 Dec;4(12):1463-8. Oncogene. 1989. PMID: 2687767

10

Chromosome 18: a possible site for a tumour suppressor gene deletion in squamous cell carcinoma of the head and neck.

Rowley H, Jones AS, Field JK. Rowley H, et al. Among authors: field jk. Clin Otolaryngol Allied Sci. 1995 Jun;20(3):266-71. doi: 10.1111/j.1365-2273.1995.tb01864.x. Clin Otolaryngol Allied Sci. 1995. PMID: 7554343

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

392 results

Search Page

Filters